High Expression of Forkhead Box Protein C2 is Related to Poor Prognosis in Human Gliomas |
Wang, Yao-Wu
(Department of Neurosurgery, The Second Hospital of Hebei Medical University)
Yin, Chun-Li (Department of Neurosurgery, Tangshan Gongren Hospital) Zhang, Hong-Yi (Department of Neurosurgery, Tangshan Gongren Hospital) Hao, Jin-Min (Department of Neurosurgery, The Second Hospital of Hebei Medical University) Yang, Yue-Ye (Department of Neurosurgery, Tangshan Gongren Hospital) Liao, Heng (Department of Neurosurgery, Tangshan Gongren Hospital) Jiao, Bao-Hua (Department of Neurosurgery, The Second Hospital of Hebei Medical University) |
1 | Bansal K, Liang ML, Rutka JT (2006). Molecular biology of human gliomas. Technol Cancer Res Treat, 5, 185-94. DOI |
2 | Feng B, Hu P, Lu SJ, et al (2014). Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis. Asian Pac J Cancer Prev, 15, 4079-83. DOI |
3 | Hollier BG, Tinnirello AA, Werden SJ, et al (2013). FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res, 73, 1981-92. DOI |
4 | Jiang W, Pang XG, Wang Q, et al (2012). Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Clin Lung Cancer, 13, 280-7. DOI |
5 | Kume T (2008). Foxc2 transcription factor: a newly described regulator of angiogenesis. Trends Cardiovasc Med, 18, 224-8. DOI ScienceOn |
6 | Kume T (2012). The role of FoxC2 transcription factor in tumor angiogenesis. J Oncol, 2012, 204593. |
7 | Li W, Fu X, Liu R, et al (2013). FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells. Oncol Res, 21, 111-20. |
8 | Liu B, Han SM, Tang XY, et al (2014). Overexpressed FOXC2 in ovarian cancer enhances the epithelial-to-mesenchymal transition and invasion of ovarian cancer cells. Oncol Rep, 31, 2545-54. |
9 | Louis DN, Ohgaki H, Wiestler OD, et al (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 114, 97-109. DOI |
10 | Mani SA, Yang J, Brooks M, et al (2007). Mesenchyme forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA, 104, 10069-74. DOI ScienceOn |
11 | Meyer MA (2008). Malignant gliomas in adults. N Engl J Med, 359, 1850. |
12 | Nishida N, Mimori K, Yokobori T, et al (2011). FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol, 18, 535-42. DOI |
13 | Reni M, Mazza E, Tosoni A, et al (2005). Novel therapeutics in adult malignant brain gliomas. Expert Opin Investig Drugs, 14, 643-58. DOI |
14 | Van Meir EG, Hadjipanayis CG, Norden AD, et al (2010). Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin, 60, 166-93. DOI |
15 | Watanabe T, Kobunai T, Yamamoto Y, et al (2011). Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. Int Surg, 96, 207-16. DOI |
16 | Wu X, Liu NF (2011). FOXC2 transcription factor: a novel regulator of lymphangiogenesis. Lymphology, 44, 35-41. |
17 | Zheng CH, Quan Y, Li YY, et al (2014). Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation. Asian Pac J Cancer Prev, 15, 1589-95. DOI |
18 | Zhu JL, Song YX, Wang ZN, et al (2013). The clinical significance of mesenchyme forkhead 1 (FoxC2) in gastric carcinoma. Histopathology, 62, 1038-48. DOI |
![]() |